Sui Generis Health (SGH) commercializes/monetizes products and/or services that are aligned with the Predictive-Preventive, Clinical & Financial mandates contained within the PPACA - specifically with platforms that focus on Chronic Condition Population Management. We review for Scientific/Clinical Validity, Clinical Utility and Predictive Analytics to include the cascading Economic Impact on Gain-Share/P4P. This is performed in accordance to existing legislative and medical policy development requirements as established/followed by CMS/VA/Commercial Insurance Carriers. The review is performed by nationally recognized subject matter experts and any/all products and/or services must meet or exceed all standards in order to be accepted as a client of SGH.